Cephalon Receives “Approvable” Letter For Fentora
The company says it will respond to FDA by the end of July; additional safety and efficacy data are not required for the fentanyl buccal tablet.
The company says it will respond to FDA by the end of July; additional safety and efficacy data are not required for the fentanyl buccal tablet.